Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 114.09 million compared to CNY 116.56 million a year ago. Revenue was CNY 114.09 million compared to CNY 116.63 million a year ago.

Net income was CNY 30.32 million compared to CNY 20.74 million a year ago. Basic earnings per share from continuing operations was CNY 0.3753 compared to CNY 0.2799 a year ago. Diluted earnings per share from continuing operations was CNY 0.3753 compared to CNY 0.2799 a year ago.